Finance

Beta
Lists
AURA:NASDAQ
Aura Biosciences Inc
$7.74
+15.01%
(+1.01) 1D
$7.74
+0.03% (+0.0021)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURA...
Open
$6.77
High
$7.75
Low
$6.58
Mkt. cap
800.60M
Avg. vol.
586.11K
Volume
961.70K
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.74
Beta
0.40
Shares outstanding
103.44M
No. of employees
113
Open
$6.77
High
$7.75
Low
$6.58
Mkt. cap
800.60M
Avg. vol.
586.11K
Volume
961.70K
52-wk high
$9.54
52-wk low
$4.73
EPS
-$1.74
Beta
0.40
Shares outstanding
103.44M
No. of employees
113
News stories
From sources across the web
About Aura Biosciences Inc
CEO-
Employees113
Founded2009
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteaurabiosciences.com
Analyst ratings
Based on 5 analysts giving stock ratings to AURA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for AURA in the last 3 months.
Highest
Current $7.74
$24.00 (+210.08%)
Average
$20.67 (+167.05%)
Lowest
$15.00 (+93.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Berens
Leerink Partners
Buy
Reiterated
-
-
06/02/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
$24.00
+210.1%
05/26/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$23.00
+197.2%
05/16/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/11/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
$15.00
+93.8%
04/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
22.88M
22.18M
21.90M
27.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.73M
5.73M
5.34M
6.91M
Operating expense
28.61M
27.91M
27.24M
34.87M
Total operating expenses
28.61M
27.91M
27.24M
34.87M
Operating income
-28.61M
-27.91M
-27.24M
-34.87M
Other non operating income
-36.00K
-13.00K
149.00K
2.00K
EBT including unusual items
-26.97M
-26.10M
-25.54M
-33.67M
EBT excluding unusual items
-26.97M
-26.10M
-25.54M
-33.67M
Income tax expense
48.00K
26.00K
15.00K
11.00K
Effective tax rate
-0.18%
-0.10%
-0.06%
-0.03%
Other operating expenses
-
-
-
-
Net income
-27.02M
-26.13M
-25.56M
-33.68M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.68M
1.82M
1.54M
1.19M
Interest expense
-
-
-
-
Net interest expenses
1.68M
1.82M
1.54M
1.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.33M
-27.63M
-26.96M
-34.59M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer